Order results by:
| Issue | Title | |
| Vol 11, No 5 (2015) | Three-year dynamics and unsolved problems of lipid-lowering therapy | Abstract similar documents |
| V. A. Sergeeva | ||
| "... регулярно принимали 26% пациентов в 2011 г. и 29% – в 2014 г. (p>0,05). Отсутствовал контроль показателей ..." | ||
| Vol 9, No 2 (2013) | MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) | Abstract similar documents |
| S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina | ||
| "... статины 34% больных контроль- ной группы, 71,6% больных подгруппы А и 61% больных подгруппы Б (p<0,05 ..." | ||
| Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
| S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
| "... у пациентов высокого и очень высокого сердечно-сосудистого риска за период 2011-2015 гг. Материал и методы ..." | ||
| Vol 12, No 3 (2016) | EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz | ||
| "... cover issues of efficacy and safety of lipid-lowering therapy in primary and secondary prevention ..." | ||
| Vol 11, No 5 (2015) | Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis | Abstract similar documents |
| N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov | ||
| "... Aim. To assess of lipid-lowering therapy with statins in very high cardiovascular risk patients ..." | ||
| Vol 6, No 1 (2010) | EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS | Abstract PDF (Eng) similar documents |
| D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova | ||
| "... физической нагрузки на 32% (p<0,001) и экономичности работы сердца при нагрузке на 12% (p<0,05), уменьшение ..." | ||
| Vol 11, No 1 (2015) | ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE | Abstract similar documents |
| M. V. Solodun, S. S. Yakushin | ||
| "... достоверного снижения уровней атерогенных липидов крови (p>0,05), в то время как у пациентов с генотипами ..." | ||
| Vol 13, No 4 (2017) | GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS | Abstract similar documents |
| M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava | ||
| "... и через 4 нед терапии аторвастатином 80 мг/сут. Результаты считали статистически значимыми при p<0,05 ..." | ||
| Vol 14, No 5 (2018) | Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov | ||
| "... Aim. To assess the economic burden associated with the absence of lipid-lowering therapy (LLT ..." | ||
| Vol 11, No 3 (2015) | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov | ||
| "... – до 4,52 ммоль/л и 2,6 ммоль/л, соответственно (p<0,05). На фоне приема статинов не было выявлено ухудшения ..." | ||
| Vol 17, No 2 (2021) | The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... and rosuvastatin is an effective drug that allows achieving not only adequate hypotensive and lipid-lowering ..." | ||
| Vol 12, No 2 (2016) | LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta | ||
| "... Aim. To study the features of lipid-lowering therapy with rosuvastatin in high and very high ..." | ||
| Vol 17, No 6 (2021) | Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident | Abstract similar documents |
| S. A. Boytsov, M. A. Piradov, M. M. Tanashyan, I. A. Voznjouk, M. V. Ezhov, E. V. Oschepkova, I. V. Sergienko, N. A. Shamalov, S. N. Yanishevskiy | ||
| "... of atherothrombotic genesis, namely lipid metabolism disorders, the modern evidence base for lipid-lowering therapy ..." | ||
| Vol 14, No 3 (2018) | HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE | Abstract similar documents |
| O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta | ||
| "... . The issues of lipid-lowering therapy with statins in the aspect of stroke prevention are discussed ..." | ||
| Vol 20, No 4 (2024) | Increased lipoprotein (a) as an additional factor in the failure to achieve target blood pressure levels and lipid spectrum optimal parameters in patients with arterial hypertension and multifocal atherosclerosis | Abstract similar documents |
| S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... received antihypertensive, lipid-lowering, and antiplatelet therapy. Results. Patients in groups ..." | ||
| Vol 17, No 1 (2021) | Lipid Clinic is an Efficacious Model of Preventive Medicine | Abstract PDF (Eng) similar documents |
| A. V. Blokhina, A. I. Ershova, A. N. Meshkov, A. S. Limonova, V. I. Mikhailina, O. M. Drapkina | ||
| "... клинику НМИЦ ТПМ в 2011-2019 гг. (n=675). Сердечно-сосудистый риск (ССР) и целевые уровни липопротеинов ..." | ||
| Vol 14, No 1 (2018) | IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION | Abstract similar documents |
| I. V. Sergienko, A. A. Ansheles | ||
| "... in patients treated with lipid-lowering drugs. Patients with lipid-lowering therapy had significantly higher ..." | ||
| Vol 14, No 6 (2018) | The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial | Abstract PDF (Eng) similar documents |
| Yu. A. Karpov | ||
| "... and discuss the clinical perspective of these data. Patients with acute coronary syndrome are at very high ..." | ||
| Vol 19, No 6 (2023) | New possibilities for lipid level control using inclisiran — prospects for interaction between a cardiologist and a neurologist | Abstract similar documents |
| A. B. Skiba, M. V. Menzorov, V. D. Puchek, I. M. Buchin, I. I. Polyakov, E. N. Menzorova | ||
| "... of combination lipid-lowering therapy for secondary prevention in patients at very high cardiovascular risk ..." | ||
| Vol 21, No 5 (2025) | Extreme hypertriglyceridemia: frequency of occurrence, clinical aspects, and efficacy of different therapeutic approaches | Abstract similar documents |
| A. V. Tyurina, T. M. Gurtsiev, U. V. Chubykina, N. A. Tmoyan, M. V. Ezhov | ||
| "... Aim. To evaluate the prevalence, clinical features, and effectiveness of various lipid-lowering ..." | ||
| Vol 2, No 3 (2006) | EFFECT OF CYTOPROTECTION ON THE OXIDATIVE PROCESSES AND ENDOTHELIAL FUNCTION IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. V. Shabalin, Yu. I. Ragino, S. A. Lyubimtseva, Ya. V. Polonskaya, M. V. Ivanova | ||
| "... возраст 74,0±0,6 лет, р>0,05) получали только базисную терапию без милдроната. Биохимический анализ крови ..." | ||
| Vol 20, No 6 (2024) | The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) | Abstract similar documents |
| K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev | ||
| "... strategy in increasing the frequency of low-density lipoprotein cholesterol (LDL-С) monitoring in patients ..." | ||
| Vol 11, No 5 (2015) | Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation | Abstract similar documents |
| E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov | ||
| "... МТ больше пациентов принимало статины (n=19; 57,6%), по сравнению с группой ТЦЗ+МТ (n=7; 18%), (p<0,05 ..." | ||
| Vol 9, No 5 (2013) | THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION | Abstract similar documents |
| R. N. Adzhiev, M. S. Safarova, M. V. Ezhov | ||
| "... рекомендациям по лечению дислипидемий от 2011 года в случае рефрактерной гиперхолестеринемии должен быть ..." | ||
| Vol 1, No 2 (2005) | ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov | ||
| "... микроальбуминурии (p<0,05) и β2-микроглобулинурии (p<0,05), восстанавливало значительно нарушенную функцию эндотелия ..." | ||
| Vol 17, No 2 (2021) | Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care | Abstract PDF (Eng) similar documents |
| S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, N. N. Shindryaeva, D. A. Klyuev, L. N. Stepanyan, A. M. Lutsenko, A. T. Tsai, A. A. Danilova | ||
| "... % и 68,0%; p>0,05) и возрасту (медиана 73,5 и 73,0 лет; p>0,05), а также по наличию сопутствующих ..." | ||
| Vol 17, No 6 (2021) | PCSK9 Inhibitors in Clinical Practice: Experience of a Specialized Lipid Center | Abstract similar documents |
| A. V. Blokhina, A. I. Ershova, A. S. Limonova, O. V. Kopylova, A. N. Meshkov, O. M. Drapkina | ||
| "... records of patients who visited the Lipid clinic of the National Medical Research Center for Therapy ..." | ||
| Vol 3, No 3 (2007) | THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| I. V. Sergienko, V. V. Kukharchuk, S. A. Gabrusenko, V. V. Malakhov, V. P. Masenko, M. I. Tripoten, T. V. Balahonova | ||
| "... терапии 2.7±1.0 ммоль/л, p<0.05). У больных, получавших милдронат, отмечено достоверное снижение уровня ..." | ||
| Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
| "... 1 на 60% (р=0,005), а в группе 2 – на 33,8% (p<0,001). Уровни КФК, креатинина и СКФ в группах сравнения ..." | ||
| Vol 9, No 5 (2013) | ASSESSING FACTORS THAT FORM PATIENT’S ATTITUDE TO TREATMENT PRECEDING HOSPITALIZATION FOR ACUTE CORONARY SYNDROM (DATA OF QUESTIONNAIRE WITHIN THE LIS REGISTER) | Abstract PDF (Eng) similar documents |
| Yu. V. Lukina, M. L. Gynzburg, V. P. Smirnov, S. Yu. Martsevich, N. P. Kutishenko, A. V. Fokina, E. V. Daniels | ||
| "... в Люберецкую районную больницу №2 с диагнозом ОКС за период с 1 декабря 2011 г. до 1 декабря 2012 г. Всего ..." | ||
| Vol 16, No 5 (2020) | Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) | Abstract similar documents |
| O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov | ||
| "... 2DS2-VASc≥2 ОАК были назначены 15% пациентов в 2011-2012 гг. и трети больных – в 2016-2017 гг. (p<0.05 ..." | ||
| Vol 18, No 3 (2022) | Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER | Abstract similar documents |
| I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk | ||
| "... II во 2-й группе (p<0,05). Показатели липидного обмена и АД при включении значимо не различались в обеих группах ..." | ||
| Vol 9, No 4 (2013) | REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) | Abstract similar documents |
| S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy | ||
| "... с высоким риском сердечно-сосудистых осложнений. Материал и методы. За период с 1 мая по 31 декабря 2011 ..." | ||
| Vol 11, No 1 (2015) | CHARACTERISTICS OF PATIENTS WITH CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK, INCLUDED INTO THE LIS-2 REGISTER (LYUBERTSY STUDY OF MORTALITY IN PATIENTS AFTER STROKE) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, A. Yu. Suvorov, M. L. Ginzburg, A. D. Deev, S. A. Boytsov, A. V. Akimova, E. V. Daniels, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov, V. P. Smirnov, A. V. Fokina | ||
| "... с 01.2009 по 12.2011. Результаты. Мужчины составили 37,5%, женщины – 62,5%, средний возраст 71,1±9,8 лет ..." | ||
| Vol 5, No 5 (2009) | ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS | Abstract similar documents |
| I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva, A. A. Sobolev, E. V. Rodygina | ||
| "... Aim. To evaluate factors affecting hypoglycemic therapy in patients with type 2 diabetes mellitus ..." | ||
| Vol 20, No 2 (2024) | Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, A. A. Kudrjavtseva, A. I. Skripka, A. V. Zhilenko, E. V. Kolpachkova, D. K. Varvarina | ||
| "... and 7 (15.2%) patients from the placebo group took constant lipid- lowering therapy. The patients did ..." | ||
| Vol 16, No 2 (2020) | Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries | Abstract similar documents |
| O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich | ||
| "... дефицит липопротеинов высокой плотности (р=0,005) в отсутствии очень высоких значений липопротеинов низкой ..." | ||
| Vol 13, No 4 (2017) | USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA | Abstract similar documents |
| O. M. Drapkina, A. S. Lishuta | ||
| "... липопротеидов низкой плотности (ХС ЛПНП) во всех исследуемых группах (p<0,05). Это продемонстрировало адекватный ..." | ||
| Vol 2, No 2 (2006) | THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL | Abstract similar documents |
| Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto | ||
| "... ±93 до 737±66 ммоль/мин/л (p<0.05), и возросла в группе, получавшей атенолол, с 937±86 до 989±88 ммоль/мин ..." | ||
| Vol 17, No 1 (2021) | Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council | Abstract similar documents |
| M. V. Ezhov, V. V. Kukharchuk, I. V. Sergienko, N. M. Akhmedzhanov, M. I. Voevoda, V. S. Gurevich, V. V. Kashtalap, V. O. Konstantinov, V. V. Skibitsky, I. I. Shaposhnik | ||
| "... of the strategy of early combined lipid-lowering therapy for doctors and these categories of patients was held ..." | ||
| Vol 14, No 6 (2018) | Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation) | Abstract PDF (Eng) similar documents |
| L. A. Khaisheva, S. E. Glova, V. A. Suroedov, A. S. Samakaev, S. V. Shlyk | ||
| "... значимо большая приверженность к ДАТ у пациентов с ОИМ по сравнению с пациентами с НС (p<0,05). При ..." | ||
| Vol 21, No 1 (2025) | Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment | Abstract similar documents |
| A. M. Namitokov, U. V. Chubykina, V. K. Zafiraki, M. V. Ezhov | ||
| "... голландских липидных клиник (Dutch Lipid Clinic Network, DLCN). Корректировка уровня холестерина липопротеидов ..." | ||
| Vol 16, No 4 (2020) | Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues | Abstract similar documents |
| M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova | ||
| "... cholesterol (LDL-C) as the primary target in addressing lipid-lowering therapy. The target level of LDL ..." | ||
| Vol 12, No 6 (2016) | State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes | Abstract PDF (Eng) similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... давления (АД). Уровень офисного систолического АД снизился на 18,8% (p<0,05), а офисного диастолического ..." | ||
| Vol 12, No 1 (2016) | State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... давления (АД). Уровень офисного систолического АД снизился на 18,8% (p<0,05), а офисного диастолического ..." | ||
| Vol 15, No 5 (2019) | Association of rs556621 Polymorphism with Development of Stroke in Patients with Cardiovascular Pathology | Abstract similar documents |
| S. Yu. Nikulina, V. A. Shulman, A. A. Chernova, S. V. Prokopenko, D. A. Nikulin, I. M. Platunova, S. S. Tretyakova, V. N. Maksimov, A. A. Gurazheva | ||
| "... не выявлено (р>0,05). Частоты генотипа ТТ были примерно одинаковы в подгруппе пациентов с артериальной ..." | ||
| Vol 13, No 3 (2017) | TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2 | Abstract similar documents |
| O. M. Drapkina, A. S. Luishuta | ||
| "... низкой плотности (ХС ЛПНП) во всех исследуемых группахх (p<0,05), что продемонстрировало адекватный ..." | ||
| Vol 10, No 5 (2014) | RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME | Abstract similar documents |
| N. V. Perova, V. A. Metelskaya | ||
| "... of dyslipidemia correction. The use of statins as lipid-lowering therapy in patients with acute coronary syndrome ..." | ||
| Vol 15, No 5 (2019) | Outpatient Register of Patients with Acute Myocardial Infarction: Assessment of the Hypertension Impact on Long-term Prognosis | Abstract similar documents |
| D. P. Sichinava, E. P. Kalaydzhyan, N. P. Kutishenko, S. Yu. Martsevich | ||
| "... и 70 мужчин, у женщин АГ регистрировалась чаще, чем мужчин (88,9% и 66,0%, соответственно, р<0,05). Пациенты ..." | ||
| Vol 9, No 2 (2013) | PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET | Abstract similar documents |
| L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova | ||
| "... -кальциевого обмена относительно их исходного уровня (р<0,05). При лечении цинакалцетом выявлено снижение ..." | ||
| Vol 16, No 1 (2020) | The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion) | Abstract similar documents |
| M. V. Ezhov, A. Catapano, C. Escobar, V. V. Kukharchuk, M. I. Voevoda, O. M. Drapkina, S. A. Shalnova, A. V. Starodubova, V. S. Gurevich, I. I. Shaposhnik, O. O. Bolshakova, O. S. Oynotkinova, A. S. Alieva | ||
| "... up with the prospect of lifelong therapy with lipid-lowering drugs. These individuals do not have an indication ..." | ||
| Vol 9, No 4 (2013) | EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE | Abstract PDF (Eng) similar documents |
| G. A. Batrak, S. E. Miasoedova, O. I. Kelesh | ||
| "... lipid levels achievement. Material and methods. The total of 161 type 2 diabetic patients ..." | ||
| Vol 7, No 6 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
| V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... with hyperlipidemia. Material and methods. Patients (6 men and 24 women) aged 38 to 77 years, which needed in lipid ..." | ||
| Vol 6, No 6 (2010) | COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE | Abstract similar documents |
| S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova | ||
| "... lipid-lowering therapy compared with standard therapy is proven in patients with both stable and acute ..." | ||
| Vol 12, No 3 (2016) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? | Abstract PDF (Eng) similar documents |
| S. N. Bel'diev | ||
| "... "; 3) unreasonably overestimated lipid-lowering activity of combination therapy with low doses of statins ..." | ||
| Vol 17, No 2 (2021) | Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 2: Treatment Options | Abstract similar documents |
| V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... in patients with multifocal arterial lesions using antihypertensive, antithrombotic and lipid-lowering therapy ..." | ||
| Vol 5, No 1 (2009) | COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina | ||
| "... на комбинированную терапию и титрование АМЛ и ГХТ в группе М проводилось чаще, чем в группе К (p>0,05). Назначение ..." | ||
| Vol 10, No 5 (2014) | STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE | Abstract similar documents |
| L. N. Malay | ||
| "... and achievements of target lipid levels in real medical practice among population of Russian patients is evaluated ..." | ||
| Vol 13, No 1 (2017) | SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION | Abstract similar documents |
| S. N. Bel'diev | ||
| "... -lowering and anti-atherogenic effects of UDCA in patients with NAFLD. This paper presents a critical ..." | ||
| Vol 21, No 3 (2025) | Effectiveness of fixed-dose combination of rosuvastatin and ezetimibe in heterozygous familial hypercholesterolemia from the RENAISSANCE registry | Abstract similar documents |
| I. A. Alekseeva, U. V. Chubykina, M. V. Ezhov, A. V. Tyurina, T. E. Kolmakova, N. A. Tmoyan, A. A. Sokolov, T. A. Rozhkova, N. S. Kurochkina, I. V. Sergienko, I. V. Avdeeva, V. E. Oleynikov, A. S. Alieva, N. G. Androsyuk, M. A. Kiselevа, Yu. G. Grigorieva, A. S. Asekritova, E. S. Kylbanova, A. V. Pavlova, A. I. Ershova, A. N. Meshkov, V. I. Mikhailina, A. V. Blokhina, A. S. Limonova, O. V. Kopylova, A. S. Vorobyev, I. D. Astrakhantseva, Yu. A. Vorobyeva, Yu. A. Ermakova, D. I. Sadykova, E. S. Slastnikova, L. F. Galimovа, I. I. Shaposhnik, V. V. Genkel, A. V. Egorova, N. V. Mukha, P. V. Vasilenko, D. N. Zaitsev, Z. F. Kim, V. K. Zafiraki, M. V. Zykov, V. A. Korneva, T. Yu. Kuznetsova, Yu. A. Malyshenko, T. I. Petelina, E. V. Mikova, A. M. Namitokov, E. D. Kosmacheva, I. I. Pshenichnikova, V. O. Konstantinov, S. E. Bednova, M. I. Voevoda, O. V. Timoshenko, Yu. I. Ragino, A. E. Filippov, A. M. Tuktarov, V. S. Gurevich, M. V. Muzalevskaya, S. A. Urazgildeevа, R. A. Khokhlov, S. V. Yarkovaya, E. A. Shutemova, E. V. Kudelkina, N. N. Bizyaeva | ||
| "... (80%) vs 86 (20%), p <0,05. Большинство пациентов предпочло ФК розувастатина и эзетимиба: 357 (74,8%) vs 120 (25,2 ..." | ||
| Vol 16, No 1 (2020) | Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease | Abstract similar documents |
| A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko | ||
| "... ) and require enhanced lipid-lowering therapy. Material and methods. The study included 49 patients (aged ..." | ||
| Vol 13, No 5 (2017) | COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES | Abstract similar documents |
| A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash | ||
| "... . В исследование включены данные 742 пациентов с ИБС, обследованных в НИИ КПССЗ в 2011 г. перед плановым ..." | ||
| Vol 11, No 1 (2015) | METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... and indapamide on insulin resistance (IR), glucose, lipid and purine metabolism in patients with arterial ..." | ||
| Vol 18, No 3 (2022) | Aromatic Amino Acids: Phenylalanine and Tyrosine in Patients with Hypertension and Coronary Artery Disease | Abstract similar documents |
| A. V. Krivova, M. V. Kozhevnikova, E. O. Korobkova, V. Yu. Zektser, E. A. Zheleznykh, А. A. Ageev, N. E. Moskaleva, A. V. Kukharenko, S. A. Appolonova, Yu. N. Belenkov | ||
| "... липопротеинов низкой плотности (ЛНП) с уровнем Фен (r=-0,685, р<0,05) и Тир (r=-0,583, р<0,05), а также уровня ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... Widespread use of antihypertensive and lipid-lowering agents in clinical practice determines ..." | ||
| Vol 18, No 3 (2022) | Assessment of the Quality of Drug Therapy in Patients with Stable Coronary Artery Disease in the Second Stage of the ALIGN Study | Abstract similar documents |
| E. D. Zharkova, S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, O. M. Drapkina | ||
| "... ), lipid-lowering drugs (p=0.008) by patients was found during the second visit. The proportion of patients ..." | ||
| Vol 13, No 2 (2017) | COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH | Abstract similar documents |
| O. M. Drapkina | ||
| "... with perindopril (as monotherapy or as a fixed combination with amlodipine or indapamide) together with lipid ..." | ||
| Vol 11, No 2 (2015) | HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... be taken into consideration). 67% of patients had good adherence to lipid-lowering therapy 3.9 years after ..." | ||
| Vol 4, No 2 (2008) | EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY | Abstract similar documents |
| A. V. Semenov, D. A. Sichev, V. G. Kukes | ||
| "... of lipid-lowering diet. Atorvastatin (80 mg once daily in the first treatment day) was given to patients ..." | ||
| Vol 13, No 5 (2017) | IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? | Abstract similar documents |
| A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova | ||
| "... prescribed antihypertensive and lipid-lowering therapy, recommendations for a healthy lifestyle. In the main ..." | ||
| Vol 16, No 1 (2020) | Cross-Sectional Study to Estimate the Prevalence of Familial Hypercholesterolemia in Selected Regions of the Russian Federation: Relevance, Design of the Study and Initial Characteristics of the Participants | Abstract similar documents |
| A. N. Meshkov, A. I. Ershova, S. A. Shalnova, A. S. Alieva, S. S. Bazhan, O. L. Barbarash, D. Y. Bogdanov, I. A. Viktorova, Yu. I. Grinshtein, D. V. Duplyakov, O. N. Kalachikova, A. V. Kontsevaya, R. A. Libis, I. V. Medvedeva, V. A. Nevzorova, N. N. Prishchepa, O. P. Rotar, V. N. Serebryakova, I. A. Trubacheva, T. M. Chernykh, E. A. Shutemova, O. M. Drapkina, S. A. Boytsov | ||
| "... Lipid Clinical Network Criteria (DLCN). Также всех участников исследования проверяют на соответствие ..." | ||
| Vol 21, No 2 (2025) | Prognostic factors for stent restenosis in patients with coronary artery disease undergoing percutaneous coronary intervention | Abstract similar documents |
| M. А. Meshkova, I. A. Starodubtseva, A. A. Pashkova | ||
| "... as the achievement of target low-density lipoprotein cholesterol level with lipid-lowering therapy. Material ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... for the effectiveness of 3-month lipid-lowering therapy was a decrease in LDL-C level by 1 mmol/l. The median ..." | ||
| Vol 8, No 5 (2012) | EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov | ||
| "... с 149,5±12,0/90,0±8,3 до 125,0±7,6/76,8±4,9 мм рт.ст (р<0,05), по результатам СМАД среднесуточное ..." | ||
| Vol 7, No 5 (2011) | ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva | ||
| "... страхования (ОМС) взяты из генерального тарифного соглашения на 2011 г . одного из субъектов России. Данные ..." | ||
| Vol 11, No 1 (2015) | MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT | Abstract similar documents |
| O. M. Drapkina, E. M. Chernova | ||
| "... Statins are lipid-lowering drugs with proven efficacy that reduce cardiovascular risk and are well ..." | ||
| Vol 10, No 2 (2014) | STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov | ||
| "... . Results. Controlled lipid-lowering therapy in combination with UDCA resulted in a significant reduction ..." | ||
| Vol 22, No 2 (2026) | 99th Percentile of High-Sensitivity Cardiac Troponin I in a Representative Sample of Healthy Individuals from the Russian Population: Data from the ESSE-RF Study | Abstract similar documents |
| N. V. Makogon, M. G. Chashchin, V. A. Kutsenko, A. A. Ivanova, S. A. Shalnova, O. M. Drapkina | ||
| "... (p>0,05). В сравнении с референтными уровнями, заявленными производителем, полученные значения для мужчин ..." | ||
| Vol 6, No 4 (2010) | CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE | Abstract similar documents |
| O. I. Afanasieva, M. V. Ezhov, M. I. Afanasieva, M. S. Safarova, J. V. Berestetskaya, S. N. Pokrovsky | ||
| "... ); 73 и 44% (p<0,05). При включении в модель множественного регрессионного анализа пола, возраста, курения ..." | ||
| Vol 9, No 6 (2013) | PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE | Abstract similar documents |
| P. V. Dolotovskaya, E. Y. Rudnichenko, N. V. Furman, O. V. Reshet'ko | ||
| "... заболевания – тромболитические (21% против 50%; p<0,05), статины (20% против 53%; p<0,05), бета ..." | ||
| Vol 12, No 5 (2016) | Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine | Abstract similar documents |
| O. V. Zimnitskaya, M. M. Petrova | ||
| "... ,99] пг/мл, соответственно; p<0,05). У пациентов с АГ III стадии был значимо выше уровень холестерина липопротеинов низкой ..." | ||
| Vol 13, No 6 (2017) | SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | Abstract similar documents |
| I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova | ||
| "... 2 (7,3±3,4 и 9,9±3,9%, p<0,01); мелких ЛПНП 3 (1,3±1,2 и 2,2±2,2%, р<0,05) и ЛПНП 4 (0,2±0,2 и 0,3±0,5%, p<0,05); сниженной ..." | ||
| Vol 6, No 4 (2010) | PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov | ||
| "... , получавших К, перевод на комбинированную терапию этим пациентам требовался реже (p>0,05). Целевые показатели ..." | ||
| Vol 10, No 3 (2014) | ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko, M. N. Titarenko, O. R. Pastuchova | ||
| "... (на 26,1% и 76,1%, соответственно; p<0,05). Отмечено увеличение доли больных с нормоциркуляторным типом ..." | ||
| Vol 12, No 5 (2016) | Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis | Abstract similar documents |
| M. V. Klimushina, N. G. Gumanova, A. Ju. Gorshkov, N. E. Gavrilova, V. A. Metel'skaja, S. A. Boytsov | ||
| "... Aim. To study the relationship between serum endothelin levels and lipid-lowering therapy ..." | ||
| Vol 14, No 3 (2018) | RELATION OF DISTURBANCES IN THE ERYTHROCYTES ELECTRICAL ACTIVITY WITH DYSLIPIDEMIA IN THE METABOLIC SYNDROME | Abstract similar documents |
| V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, M. G. Kudryavtseva, G. I. Bragina, M. V. Pisarev | ||
| "... у больных МС (1,59±0,05×107) была статистически значимо ниже, чем в группе контроля (1,65±0,03×107; р<0,05 ..." | ||
| Vol 16, No 1 (2020) | An Attempt to Accord the Quality of Therapy of Stable Coronary Heart Disease Patients with Current Clinical Guidelines (ALIGN study): Design and the First Results | Abstract similar documents |
| S. Yu. Martsevich, E. D. Zharkova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, A. V. Zagrebelnyy | ||
| "... %, diabetes mellitus – in 21.1%, atrial fibrillation – in 15.5% of patients. Lipid-lowering drugs were taken ..." | ||
| Vol 7, No 3 (2011) | COMPARATIVE ANALYSIS OF ARTERIAL HYPERTENSION TREATMENT IN MEN AND WOMEN BASED ON THE RESULTS OF ACCORD STUDY (ACRIDILOLE IN COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY OR TYPE 2 DIABETES) | Abstract similar documents |
| S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, Yu. V. Lukina, E. N. Hoseva | ||
| "... между группами терапии были статистически значимыми (p<0,05). К концу исследования целевой уровень ..." | ||
| Vol 19, No 2 (2023) | Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity? | Abstract similar documents |
| A. M. Chaulin, D. V. Duplyakov | ||
| "... . In addition to the key lipid-lowering effect of statins associated with the inhibition of the ratelimiting ..." | ||
| Vol 10, No 5 (2014) | THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. E. Zakirova, A. N. Zakirova | ||
| "... ; р<0,05) и величинами ЭЗВД, ЭТ-1 и Е-селектина (r=-0,44; 0,52; 0,49, соответственно; р<0,05). Установлены ..." | ||
| Vol 12, No 5 (2016) | Statins in Secondary Prevention of Atrial Fibrillation | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... за больными проводилось с 2011 по 2015 г., эволюцию клинического течения ФП оценивали на основании подсчета ..." | ||
| Vol 19, No 5 (2023) | Gender and age features of dyslipidemia in the population of the Nizhny Novgorod region | Abstract similar documents |
| N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, T. E. Bakka, N. K. Pershina, E. S. Timoshchenko, A. A. Nekrasov, E. A. Ovchinnikova, N. N. Savickaya, M. A. Mironov, Yu. A. Balanova, A. E. Imaeva, A. V. Kontsevaya | ||
| "... sampling, 276 people (11,0%) were receiving lipid-lowering drugs. They were excluded from further analysis ..." | ||
| Vol 6, No 4 (2010) | EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE | Abstract similar documents |
| M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya | ||
| "... 24 нед – на 14,7 и 7,2%, соответственно (p<0,05). Целевые уровни АД достигнуты у 85% пациентов ..." | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE | Abstract similar documents |
| R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov | ||
| "... АД суточное (с 91,7±1,8 до 78,7±1,6 мм рт. ст. p<0,05), дневное (с 94,3±1,3 до 85,0±1,2 мм рт. ст. p<0,05 ..." | ||
| Vol 6, No 3 (2010) | ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION | Abstract PDF (Eng) similar documents |
| T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov | ||
| "... , p<0,05), при наличии ожирения (ОШ 1,57, р=0,005), сахарного диабета (ОШ 3,33, р<0,0001). При анализе ..." | ||
| Vol 16, No 2 (2020) | Clinical profile and drug therapy of outpatients with arterial hypertension | Abstract similar documents |
| N. V. Izmozherova, A. A. Popov, V. M. Bakhtin, M. A. Shambatov | ||
| "... cardiovascular risk, which requires lipid-lowering and antiplatelet therapy. ..." | ||
| Vol 7, No 5 (2011) | COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN | Abstract similar documents |
| E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
| "... существенно меньше — 5 (25%) пациентов (χ2=5,05; р<0,05). Значимого увеличения уровня креатинфосфокиназы ..." | ||
| Vol 10, No 3 (2014) | THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) | Abstract similar documents |
| M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev | ||
| "... (1,0; 2,4), первичная конечная точка – общая смертность. 2-ой этап работы – продолжение регистра «ЛИС-1» (период 2011 ..." | ||
| Vol 13, No 3 (2017) | ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING | Abstract similar documents |
| A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya | ||
| "... /л и гомоцистеина на 0,9 (0,17-2,69) мкмоль/л (p<0,05 для обоих). Заключение. Предполагается, что метаболические ..." | ||
| 1 - 99 of 99 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
.jpg)
